[ORGANIZATION]
ipilimumab
Featured in 2 tracked stories · first seen
Also covered in
-
MD Anderson trial finds local therapy adds no survival benefit in NSCLC
[HEALTH] · 3 sources ·
-
Fondazione Nibit researchers identify mechanism for melanoma immunotherapy resistance
[HEALTH] · 33 sources ·